LV13060B - Feline leukemia virus vaccines - Google Patents
Feline leukemia virus vaccines Download PDFInfo
- Publication number
- LV13060B LV13060B LVP-03-67A LV030067A LV13060B LV 13060 B LV13060 B LV 13060B LV 030067 A LV030067 A LV 030067A LV 13060 B LV13060 B LV 13060B
- Authority
- LV
- Latvia
- Prior art keywords
- felv
- dose
- gag
- vaccine
- virus
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/86—Viral vectors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
- A61K2039/541—Mucosal route
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/14011—Baculoviridae
- C12N2710/14111—Nucleopolyhedrovirus, e.g. autographa californica nucleopolyhedrovirus
- C12N2710/14141—Use of virus, viral particle or viral elements as a vector
- C12N2710/14143—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/13011—Gammaretrovirus, e.g. murine leukeamia virus
- C12N2740/13022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/13011—Gammaretrovirus, e.g. murine leukeamia virus
- C12N2740/13034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Virology (AREA)
- Genetics & Genomics (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Medicinal Chemistry (AREA)
- Biomedical Technology (AREA)
- Oncology (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Zoology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Communicable Diseases (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Plant Pathology (AREA)
- Physics & Mathematics (AREA)
- Microbiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US78916391A | 1991-11-08 | 1991-11-08 | |
| US85706492A | 1992-03-25 | 1992-03-25 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| LV13060B true LV13060B (en) | 2003-12-20 |
Family
ID=27120881
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| LVP-03-67A LV13060B (en) | 1991-11-08 | 2003-06-19 | Feline leukemia virus vaccines |
Country Status (12)
| Country | Link |
|---|---|
| EP (2) | EP0611397B1 (es) |
| JP (1) | JP2852395B2 (es) |
| KR (1) | KR100265393B1 (es) |
| AT (1) | ATE219520T1 (es) |
| AU (2) | AU672372B2 (es) |
| CA (1) | CA2120137C (es) |
| DE (1) | DE69232650T2 (es) |
| DK (1) | DK0611397T3 (es) |
| ES (1) | ES2177530T3 (es) |
| LV (1) | LV13060B (es) |
| MX (1) | MX9206018A (es) |
| WO (1) | WO1993009238A1 (es) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6090379A (en) * | 1992-04-29 | 2000-07-18 | Boyce Thompson Institute For Plant Research, Inc. | Stable pre-occluded virus particle for use in recombinant protein production and pesticides |
| US5593669A (en) * | 1992-04-29 | 1997-01-14 | Boyce Thompson Institute For Plant Research, Inc. | Stable pre-occluded virus particle |
| ATE243259T1 (de) * | 1992-04-29 | 2003-07-15 | Thompson Boyce Plant Res | Mundinfektion der insektlarven mit prä- okkludierten bakuloviruspartikeln |
| FR2715664B1 (fr) * | 1994-01-31 | 1996-04-12 | Proteine Performance Sa | Baculovirus recombinant et son utilisation pour la production d'anticorps monoclonaux. |
| CA2158977A1 (en) | 1994-05-09 | 1995-11-10 | James G. Respess | Retroviral vectors having a reduced recombination rate |
| US6013517A (en) * | 1994-05-09 | 2000-01-11 | Chiron Corporation | Crossless retroviral vectors |
| US6248582B1 (en) * | 1997-10-08 | 2001-06-19 | Imran Khan | Gene deleted recombinant FeLV proviral DNA for production of vaccines against FeLV |
| KR20190062084A (ko) | 2017-11-28 | 2019-06-05 | 주식회사 제트바이오텍 | 고양이 백혈병 바이러스 검출용 프라이머 및 이를 포함한 진단 키트 |
| CN109679970B (zh) * | 2018-11-20 | 2020-12-08 | 杭州贤至生物科技有限公司 | 猫疱疹i型病毒快速检测的制备方法 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0173997A1 (en) * | 1984-09-06 | 1986-03-12 | Chiron Corporation | Feline leukemia virus protein vaccines and their preparation |
| AU607399B2 (en) * | 1985-09-09 | 1991-03-07 | Cetus Corporation | Infectious recombinant virus vaccine for feline leukemia |
| GR862412B (en) * | 1985-09-25 | 1987-01-23 | Oncogen | Vaccines and immuinoassays for acquired immune deficiency syndrome |
| ZA867281B (en) * | 1985-09-25 | 1987-05-27 | Oncogen | Vaccines and immunoassays for acquired immune deficiency syndrome |
| GB8523999D0 (en) * | 1985-09-30 | 1985-11-06 | Jabay Ltd | Injection of liquid into meat |
| WO1987007301A1 (en) * | 1986-05-30 | 1987-12-03 | Cambridge Bioscience Corporation | Method of preparation and use for feline leukemia virus antigens |
| EP0427788B1 (en) * | 1988-08-08 | 1995-11-22 | The Upjohn Company | Methods for isolating herpes virus thymidine kinase-encoding dna |
| ES2052478T1 (es) * | 1989-11-20 | 1994-07-16 | Oncogen | Particulas retrovirales no replicantes producidas de forma recombinante empleadas como agentes antivirales e inmunogenos. |
-
1992
- 1992-10-08 DK DK92922254T patent/DK0611397T3/da active
- 1992-10-08 AU AU28923/92A patent/AU672372B2/en not_active Ceased
- 1992-10-08 KR KR1019940701531A patent/KR100265393B1/ko not_active IP Right Cessation
- 1992-10-08 ES ES92922254T patent/ES2177530T3/es not_active Expired - Lifetime
- 1992-10-08 CA CA002120137A patent/CA2120137C/en not_active Expired - Fee Related
- 1992-10-08 JP JP5508416A patent/JP2852395B2/ja not_active Expired - Fee Related
- 1992-10-08 AT AT92922254T patent/ATE219520T1/de not_active IP Right Cessation
- 1992-10-08 WO PCT/US1992/008427 patent/WO1993009238A1/en active IP Right Grant
- 1992-10-08 EP EP92922254A patent/EP0611397B1/en not_active Expired - Lifetime
- 1992-10-08 DE DE69232650T patent/DE69232650T2/de not_active Expired - Fee Related
- 1992-10-08 EP EP01102749A patent/EP1136562A3/en not_active Withdrawn
- 1992-10-20 MX MX9206018A patent/MX9206018A/es not_active IP Right Cessation
-
1996
- 1996-01-23 AU AU42134/96A patent/AU689355B2/en not_active Ceased
-
2003
- 2003-06-19 LV LVP-03-67A patent/LV13060B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| DE69232650T2 (de) | 2002-11-28 |
| WO1993009238A1 (en) | 1993-05-13 |
| KR100265393B1 (ko) | 2000-10-02 |
| EP0611397B1 (en) | 2002-06-19 |
| EP1136562A3 (en) | 2003-06-25 |
| DK0611397T3 (da) | 2002-10-07 |
| ATE219520T1 (de) | 2002-07-15 |
| AU4213496A (en) | 1996-04-26 |
| AU672372B2 (en) | 1996-10-03 |
| CA2120137A1 (en) | 1993-05-13 |
| JP2852395B2 (ja) | 1999-02-03 |
| JPH06510910A (ja) | 1994-12-08 |
| CA2120137C (en) | 2004-05-04 |
| AU2892392A (en) | 1993-06-07 |
| EP0611397A1 (en) | 1994-08-24 |
| DE69232650D1 (de) | 2002-07-25 |
| AU689355B2 (en) | 1998-03-26 |
| ES2177530T3 (es) | 2002-12-16 |
| MX9206018A (es) | 1993-05-01 |
| EP1136562A2 (en) | 2001-09-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US5833993A (en) | Feline immunodeficiency virus vaccine | |
| Kuroda et al. | Expression of the influenza virus haemagglutinin in insect cells by a baculovirus vector. | |
| US5420026A (en) | Self-assembling replication defective hybrid virus particles | |
| US5849303A (en) | Recombinant feline Immunodeficiency virus subunit vaccines employing baculoviral-expressed envelope glycoproteins derived from isolate NCSU-1 and their use against feline immunodeficiency virus infection | |
| CA2111116A1 (en) | Improved expression of influenza a m2 protein in baculovirus and uses of m2 protein | |
| CN113461788B (zh) | 猫冠状病毒重组抗原、其基因工程亚单位疫苗及应用 | |
| JPS63207397A (ja) | 組換えバキュロウイルスに感染した昆虫細胞においてヒト免疫不全ウイルスのエンベロープ遺伝子から誘導されたポリペプチド | |
| Sondermeijer et al. | Avian herpesvirus as a live viral vector for the expression of heterologous antigens | |
| EP0611397B1 (en) | Feline leukemia virus vaccines | |
| US5443828A (en) | Chimeric HIV-2 gag particles | |
| CN113896773B (zh) | 重组fcv抗原及猫嵌杯病毒基因工程亚单位疫苗 | |
| US5631154A (en) | Self assembled, defective, non-self-propagating lentivirus particles | |
| US6013506A (en) | Feline leukemia virus vaccines | |
| Roy | From genes to complex structures of bluetongue virus and their efficacy as vaccines | |
| CN112094354B (zh) | 副鸡禽杆菌基因工程亚单位疫苗、其制备方法及应用 | |
| Zhao et al. | Construction and immune protection evaluation of recombinant virus expressing Newcastle disease virus F protein by the largest intergenic region of fowlpox virus NX10 | |
| McClintock et al. | Protein synthesis in gypsy moth cells infected with a nuclear polyhedrosis virus of Lymantria dispar | |
| Masahiro et al. | Characterization of haemagglutinin-neuraminidase glycoprotein of Newcastle disease virus expressed by a recombinant baculovirus | |
| Ong et al. | Cloning and expression of the HN gene from the velogenic viscerotropic Newcastle disease virus strain AF2240 in Sf9 insect cells | |
| KR870003192A (ko) | 후천성 면역결핍증용 백신 및 면역검사법 | |
| Kazuaki et al. | Characterization of baculovirus-expressed hemagglutinin and fusion glycoproteins of the attenuated measles virus strain AIK-C | |
| CN116063406A (zh) | 一种猫传染性鼻气管炎疫苗及其制备方法和应用 | |
| Li et al. | The expression of the Autographa californica nuclear polyhedrosis virus genome in insect cells |